← Back to Home

When Your Aligner Supplier Disappears: Why Chairside Production Is Your Safety Net

Over the past few years the clear aligner industry has gone through a sharp consolidation. A major direct-to-consumer pioneer filed for bankruptcy; across Asia, several regional aligner manufacturers and branded clinic chains have closed abruptly, leaving treatment plans half-finished and patients mid-course. This is not a story about one bad company. It is a structural feature of a market that grew fast on outside capital and then had to stand on its own economics.

If you run a clinic or a dental lab, the question worth asking is not “how do I avoid a supplier that might fail?” — you cannot reliably predict that. The right question is: if my supplier stops tomorrow, can I still finish my patients?

What actually breaks when a provider closes

Most clinics assume the loss is a supply issue. In practice, three things break, and only the first one is obvious:

• The production pipeline. Nobody is cutting trays any more. If a patient is on aligner 12 of 30, steps 13 to 30 simply do not exist.
• Access to the treatment plan. In many service models the digital plan was never yours. It sits in the provider’s cloud, in a proprietary format, behind an account that no longer answers email.
• The ability to reproduce a single tray. A tray is lost, cracked, or chewed by the family dog more often than anyone admits. With a closed service model, a replacement can only come from the same supplier — the one that no longer exists.

The three failure modes you will actually face

Across the clinics and labs we speak with, the same three scenarios recur:

1. The single lost or broken tray. Treatment is progressing normally, one tray is damaged, and there is no way to re-make it.
2. Treatment restart. The patient needs a new scan and a new plan — but the original digital setup is inaccessible, so everything is rebuilt from zero.
3. Supplier exit mid-treatment. The provider stops operating entirely while patients are still in active treatment.

Why “just switch suppliers” does not solve it

Switching is the intuitive answer, and it works only if the plan is portable. In a locked-in workflow, it is not. The new provider receives no usable digital setup, so the case restarts — new scan, new planning, new fee, and a patient who has to be told that months of progress are being rebuilt. Patients rarely experience that as a technicality.

Portability is therefore the real question, and it comes down to one file format. If your treatment planning lives in standard open STL, any compatible system can cut from it. If it lives inside a vendor’s proprietary pipeline, it is only as durable as that vendor.

What chairside production actually changes

Cutting aligners on your own bench from your own files changes the risk profile in a specific, non-magical way:

• The files stay with you. Open STL is an ISO-standard interchange format. It is not licensed, it does not expire, and it does not require an account.
• A lost tray becomes a same-day task. Re-cutting an existing tray is a production step, not a commercial negotiation.
• A supplier’s closure stops being a clinical event. It becomes an inconvenience, because the plan and the means of producing it are already in the building.

What you need for it to work in practice

In-house production is a workflow, not just a purchase. Before committing, confirm four things:

• Open-format input. The machine must read standard STL from any design software — not a proprietary container.
• Real cutting accuracy. ±0.05mm positional accuracy is the working floor for a clean margin, across the full thickness range you intend to use (the SC-002 covers 0.38–4.0mm).
• Operational simplicity. Someone on your existing team must be able to run it after structured training. A machine that needs a dedicated engineer is a new dependency, not less risk.
• No recurring licence lock. If you must keep paying a third party to keep producing, you have not removed the dependency — you have renamed it.

The honest summary

No machine guarantees that a supplier will survive, and nobody can promise that a treatment will be easy. What a chairside cutting setup does is narrower and more useful: it moves the ability to produce from a company you do not control to a bench you do. In an industry that has just demonstrated how quickly a provider can disappear, that is the difference between a supply interruption and a clinical crisis.